Dizal Pharmaceutical(SH:688192) Xin Lang Cai Jing·2025-10-31 02:20Group 1 - The core viewpoint of the news is that Dize Pharmaceutical (688192.SH) has seen significant institutional investment, with 72 institutional investors holding a total of 332 million shares, representing 72.22% of the total share capital as of October 30, 2025 [1] - The top ten institutional investors collectively hold 66.66% of the shares, with a slight increase of 0.15 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 24 funds increased their holdings, accounting for 1.45% of the total, while 27 funds decreased their holdings, representing a reduction of 0.38% [2] - Eight new public funds were disclosed this period, while 312 funds were not disclosed compared to the previous quarter [2] - One new foreign institution, Hong Kong Central Clearing Limited, was disclosed this period [2]